title: [Update on current care guidelines: urinary incontinence (female)].
abstract: Female urinary incontinence (UI) is divided into stress (SUI), urgency (UUI), mixed (MUI) and overflow incontinence (chronic retention). Advanced age, obesity and pregnancy are the most important risk factors. Standardised questionnaires are used in diagnosis. The pad test, cough stress test and bladder diary are objective tools. A gynaecological examination includes pelvic floor muscle palpation and residual urine measurement. Urodynamics, cystoscopy and ultrasonography are complementary tools. Guided pelvic floor-muscle training is the first-line therapy. UUI can be treated with anticholinergic medicines. If conservative treatments are ineffective, SUI and MUI can be treated surgically with mid-urethral slings (TVT TOT and TVT-0).
mesh_terms: D000367:Age Factors; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D003558:Cystoscopy; D005260:Female; D006801:Humans; D009765:Obesity / Q000150:complications; D010173:Palpation; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D012307:Risk Factors; D053825:Suburethral Slings; D011795:Surveys and Questionnaires; D014549:Urinary Incontinence / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D014563:Urodynamics
chemical_list: D018680:Cholinergic Antagonists